Drw Securities, L.L.C. Repligen Corp Transaction History
Drw Securities, L.L.C.
- $4.72 Billion
- Q3 2022
A detailed history of Drw Securities, L.L.C. transactions in Repligen Corp stock. As of the latest transaction made, Drw Securities, L.L.C. holds 10,600 shares of RGEN stock, worth $1.5 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
10,600Holding current value
$1.5 Million% of portfolio
0.04%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding RGEN
# of Institutions
486Shares Held
54.3MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.07 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$906 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$715 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$230 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$201 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.87B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....